Antimicrobial Therapeutics and Drug Discovery

Name: Antimicrobial Therapeutics and Drug Discovery
Price: 175 USD
Availability: InStock
ISBN: 9780443365188

by Chengyuan Liang, Lei Tian

1st Edition

Publisher: Academic Press

(0 reviews)

Pharmacology

Compare Prices

VitalSourceLifetime Access$175.00 AmazonKindle$140.00 Best PriceeTextShelfPDF$38.00

Book Details

Print ISBN	9780443365188
eText ISBN	9780443365195
Publisher	Academic Press
Publishing Year	2026
Edition	1st Edition
Language	English
Pages	770

Antimicrobial Therapeutics and Drug Discovery, 1st Edition, edited by Chengyuan Liang and Lei Tian, is a 770-page reference work published by Academic Press. The text provides comprehensive technical coverage of drug discovery frameworks and pathogen resistance mechanisms for pharmacologists, pharmaceutical scientists, medicinal chemists, and microbiologists. It establishes a broad reference framework intended to support research professionals in evaluating antimicrobial design across laboratory settings.

The volume focuses extensively on antibacterial drug discovery alongside the complex molecular mechanisms of antibiotic resistance. It presents detailed analytical perspectives on how bacterial pathogens evade conventional treatments, offering essential scientific context for identifying novel biological targets and developing effective therapeutic agents.

To address evolving clinical challenges, the publication outlines next-generation strategies, incorporating computational approaches, multi-omics platforms, nanomedicine technologies, drug repurposing, and strategic drug combinations. This structured coverage provides academic research professionals and corporate research professionals with a clear foundation for guiding modern antimicrobial research projects.

Chapter 1: Exploring Viral and Host Targets for Antiviral Drug Discovery
Chapter 2: COVID-19 Challenges and its Therapeutics
Chapter 3: From Lab to Clinic: The Evolution of Reverse Transcriptase Inhibitors in HIV Treatment
Chapter 4: Targeting Hepatitis C Virus Polymerase: Non-Nucleoside Inhibitors (NNIs) and Drug Resistance
Chapter 5: Challenges, Progress, and Prospects of Drug Discovery to Treat Chronic Hepatitis B (CHB) Infection
Chapter 6: Discovery and Development of Antiviral Therapies for Influenza Virus Infections
Chapter 7: Medicinal Chemistry Strategies for the Discovery and Development of Anti-Herpesvirus Drugs
Chapter 8: Opportunities and Challenges in Targeted Protein Degradation for Antiviral Drug Discovery
Chapter 9: Molecular Mechanisms of Antibiotic Resistance
Chapter 10: Overview of the Antibiotics Approved in the Last Two Decades: Retrospect and Prospect
Chapter 11: Antibiotic Resistance Breakers: Current Approaches and Future Directions
Chapter 12: Innovative Approaches in Developing Antimicrobial Peptides for Drug-Resistant Bacterial Infections
Chapter 13: The Potential of Antibody-Antibiotic Conjugates in Combatting Bacterial Diseases
Chapter 14: Phage Therapy: Current Advancements and Future Prospects in Combating Antimicrobial Resistance
Chapter 15: Antifungal Drug Resistance: Current Mechanisms and Future Directions
Chapter 16: Challenges, Unmet Clinical Needs, and Novel Approaches in the Discovery of Antifungal Drugs
Chapter 17: Drug Discovery against Mycobacteria: The Success and Challenges
Chapter 18: Future of Drug Development for the Treatment of Mycoplasma Infections
Chapter 19: Antimalarial Drug Discovery: From Novel Molecules to Clinical Development
Chapter 20: Computational Approaches in Antimicrobial Drug Discovery
Chapter 21: Multi-Omics Approaches for Antimicrobial Drug Discovery
Chapter 22: Nanomedicine as a Next-Generation Antimicrobial Therapy: New Frontiers in Fighting Microbial Infections
Chapter 23: Drug Repurposing: Innovative Antimicrobial Strategies to Combat Resistance
Chapter 24: Drug Combinations: A Strategy to Extend the Life of Antimicrobials
Chapter 25: Ethical Imperatives in Combating Antimicrobial Resistance: A Global Perspective